Australia's most trusted
source of pharma news
Friday, 18 October 2024
Posted 24 July 2024 PM
Australia has become the first country in the world to add mastitis and breast swelling as potential adverse events to the Product Information (PI) of Covid mRNA vaccines.
Mastitis (including breast swelling) was identified as a signal through the TGA's routine safety monitoring activities and warranted further investigation into Covid vaccines, according to a TGA spokesperson.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.